Nanjing Haina Medical Technology Co.
Latest round
- Series B
Last raised
- Aug 2022
Total raised
- $15M
Investors
- 1
About Nanjing Haina Medical Technology Co.
,Ltd. operates as a pharmaceutical developer that provides new drug development process services. The company's R & D area has exceeded 5000 square meters and the investment exceeds CNY 400 million. The R&D team divides into synthesis department, preparation department and analysis department., Ltd., Ltd. are the subsidiary of the company. Boda medicine has become the strategic partner of the company in July 2021., Ltd.,Ltd. The business of the company includes new drug discovery, pharmaceutical and clinical research, biological sample detection. The company's products and services include contract development and manufacturing organization (CDMO) services, consistency evaluation, technology transfer, technical service and clinical services. Consistency evaluation includes oral solid preparation and injection consistency evaluation. Technology transfer includes transfer of clinical approval documents for guanfaxin hydrochloride raw materials and tablets, transfer of clinical approval documents for fluconazole raw materials and liniments, transfer of clinical approval documents for pirepanide raw materials and tablets. The company's R&D platforms include drug synthesis platform, drug preparation platform impurity analysis, impurity analysis platform and pharmacokinetic research platform. Impurity analysis platform includes study on genotoxic impurities, synthesis, separation and preparation of impurities. The company’s revenue is generated by providing services and integrated solutions for the entire process of new drug development.
Who invested in Nanjing Haina Medical Technology Co.
1 investor across 1 round
See all investors in Nanjing Haina Medical Technology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Aug 12, 2022
Amount
$15M
Investors
Questions about Nanjing Haina Medical Technology Co.
Who invested in Nanjing Haina Medical Technology Co.?
Nanjing Haina Medical Technology Co. has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nanjing Haina Medical Technology Co. raised?
Nanjing Haina Medical Technology Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Nanjing Haina Medical Technology Co. last raise money?
Nanjing Haina Medical Technology Co.'s most recent round on record is a Series B, in Aug 2022.
What does Nanjing Haina Medical Technology Co. do?
Nanjing Haina Medical Technology Co. is a pharmaceuticals company.
Where is Nanjing Haina Medical Technology Co. headquartered?
Nanjing Haina Medical Technology Co. is headquartered in Nanjing, China.
Which VCs invest in companies like Nanjing Haina Medical Technology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Nanjing Haina Medical Technology Co.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Nanjing Haina Medical Technology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.